The Brazil Clinical Nutrition for Diabetes Care Market was valued at $53.75 Mn in 2023 and is predicted to grow at a CAGR of 5.78% from 2023 to 2030, to $79.65 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Nutribio, Pfizer Inc., and Novo Nordisk among others.
The UAE Clinical Nutrition for Diabetes Care Market was valued at $10.75 Mn in 2023 and is predicted to grow at a CAGR of 5.78% from 2023 to 2030, to $15.93 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestlé Health Science, Eli Lily, Baxter International, Boehringer Ingelheim, and among others.
The Saudi Arabia Clinical Nutrition for Diabetes Care Market was valued at $36.55 Mn in 2023 and is predicted to grow at a CAGR of 6.28% from 2023 to 2030, to $55.98 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Sanofi, Nestlé Health Science, Danone Nutricia, and Novo Nordisk among others.
The US Clinical Nutrition for Diabetes Care Market was valued at $903 Mn in 2023 and is predicted to grow at a CAGR of 2.78% from 2023 to 2030, to $1094.08 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Perrigo Company PLC, Eli Lilly, and Baxter International Inc. among others.
The Canada Clinical Nutrition for Diabetes Care Market was valued at $172 Mn in 2023 and is predicted to grow at a CAGR of 4.78% from 2023 to 2030, to $238.49 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Eli Lily, Danone, AgaMatrix Inc., and among others.
The India Pharmacy Automation Device Market was valued at $100 Mn in 2023 and is predicted to grow at a CAGR of 12.9% from 2023 to 2030, to $233.9 Mn by 2030. India Pharmacy Automation Device Market is growing due to Increasing Healthcare Expenditure, Rising Chronic Disease Burden, Cost Containment and Efficiency. The market is primarily dominated by players such as Cotmac Electronics Pvt Ltd, Zifo Technologies, Becton Dickinson and Company, Omron Healthcare Co Ltd, Capsa Solutions, LLC, Pearson Medical Technologies LLC, Cotmac Electronics Pvt Ltd, Baxter; Talyst, LLC.
The South Africa Pharmacy Automation Device Market was valued at $35.8 Mn in 2023 and is predicted to grow at a CAGR of 11.13% from 2023 to 2030, to $74.8 Mn by 2030. South Africa Pharmacy Automation Device Market is growing due to Growing Need to Minimize Medication Errors, Increasing Healthcare Expenditure, and Advancing Technology. The market is primarily dominated by players such as Cerner Corporation, Capsa Healthcare, ScriptPro LLC, RxSafe, LLC., MedAvail Technologies, Amerisource Bergen Corporation, and Omnicell, Inc.
The Kenya Pharmacy Automation Device Market was valued at $3.9 Mn in 2023 and is predicted to grow at a CAGR of 11% from 2023 to 2030, to $8 Mn by 2030. Kenya Pharmacy Automation Device Market is growing due to Growing Need to Minimize Medication Errors, Rising Demand for Pharmaceuticals, Government Initiatives, and Investments. The market is primarily dominated by players such as Becton Dickinson and Co, Capsa Solutions LLC, Omnicell Inc, Oracle Corp, Veradigm LLC, Swisslog Healthcare AG, McKesson Corporation; and Pearson Medical Technologies.
The Egypt Pharmacy Automation Device Market was valued at $15.4 Mn in 2023 and is predicted to grow at a CAGR of 11.4% from 2023 to 2030, to $32.8 Mn by 2030. Egypt Pharmacy Automation Device Market is growing due to Adoption of Electronic Health Records, Growing Need to Minimize Medication Errors, Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Becton Dickinson and Co, Capsa Solutions LLC, Omnicell Inc, Oracle Corp, Veradigm LLC, Swisslog Healthcare AG, McKesson Corporation; Pearson Medical Technologies.
The Vietnam Pharmacy Automation Device Market was valued at $27.5 Mn in 2023 and is predicted to grow at a CAGR of 10.13% from 2023 to 2030, to $54 Mn by 2030. Vietnam Pharmacy Automation Device Market is growing due to Adoption of Electronic Health Records, Growing Need to Minimize Medication Errors, Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Kawasaki Heavy Industries Ltd., Fanuc Corporation, Kuka Ag, Mitsubishi Electric Corporation, Becton Dickinson and Co, Capsa Solutions LLC, McKaesson Corporation; Pearson Medical Technologies.
The Singapore Pharmacy Automation Device Market was valued at $6.6 Mn in 2023 and is predicted to grow at a CAGR of 10.5% from 2023 to 2030, to $13.3 Mn by 2030. Singapore Pharmacy Automation Device Market is growing due to Demand for Efficiency, Rising Demand for Pharmaceuticals, and end-user adoption. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC.
The Philippines Pharmacy Automation Device Market was valued at $12.1 Mn in 2023 and is predicted to grow at a CAGR of 10.4% from 2023 to 2030, to $24.2 Mn by 2030. Philippines Pharmacy Automation Device Market is growing due to Adoption of Electronic Health Records, Growing Need to Minimize Medication Errors, Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Becton Dickinson and Co, Capsa Solutions LLC, Omnicell Inc, Oracle Corp, Veradigm LLC, Swisslog Healthcare AG, McKaesson Corporation; Pearson Medical Technologies, Baxter; Talyst.
The Malaysia Pharmacy Automation Device Market was valued at $8.8 Mn in 2023 and is predicted to grow at a CAGR of 10.1% from 2023 to 2030, to $17.3 Mn by 2030. Malaysia Pharmacy Automation Device Market is growing due to Growing Healthcare Expenses, Increased Medication Errors, Technological Advancements. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC.
The Japan Pharmacy Automation Device Market was valued at $341.9 Mn in 2023 and is predicted to grow at a CAGR of 10.4% from 2023 to 2030, to $683.4 Mn by 2030. Japan Pharmacy Automation Device Market is growing due to Reducing Human Errors, Adoption of Electronic Health Records, and Increased Demand for Pharmaceuticals. The market is primarily dominated by players such as Omron Corporation, Panasonic Corporation, Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., and McKesson Corporation.
The Indonesia Pharmacy Automation Device Market was valued at $33 Mn in 2023 and is predicted to grow at a CAGR of 9.9% from 2023 to 2030, to $63.9 Mn by 2030. Indonesia Pharmacy Automation Device Market is growing due to Increasing Healthcare Expenditure, Adoption of Electronic Health Records, and Advancing Technology. The market is primarily dominated by players such as Touchpoint Medical, Swisslog Healthcare, Kawasaki Heavy Industries Ltd, Fanuc Corporation, Kuka Ag, Mitsubishi Electric Corporation Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc.
The China Pharmacy Automation Device Market was valued at $442.1 Mn in 2023 and is predicted to grow at a CAGR of 11.4% from 2023 to 2030, to $941.3 Mn by 2030. China Pharmacy Automation Device Market is growing due to Reducing Human Errors, Increasing adoption among end-users and Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Shanghai Fosun Pharmaceutical, WuXi AppTec Co, Amerisource Bergen Corporation, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC.
The UK Pharmacy Automation Device Market was valued at $143 Mn in 2023 and is predicted to grow at a CAGR of 7.9% from 2023 to 2030, to $243.5 Mn by 2030. UK Pharmacy Automation Device Market is growing due to Reducing Human Errors, Adoption of Electronic Health Records, and Increased Demand for Pharmaceuticals. The market is primarily dominated by players such as Chemist Outsource, Paragon Group, Meda UK , KUKA AG, Parata Systems LLC, Dickinson, and Company, Talyst Systems.
The Spain Pharmacy Automation Device Market was valued at $106.2 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $192.8 Mn by 2030. Spain Pharmacy Automation Device Market is growing due to Increasing Demand for Efficiency, Adoption of Electronic Health Records, Increasing adoption among end-users. The market is primarily dominated by players such as KUKA AG, Parata Systems LLC, Dickinson, and Company, Talyst Systems, LLC, Becton, ScriptPro LLC, RxSafe, LLC, Capsa Healthcare, McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC, Becton Dickinson and Company, Fulcrum Pharmacy Management, Inc.
The Germany Pharmacy Automation Device Market was valued at $201.3 Mn in 2023 and is predicted to grow at a CAGR of 8.1% from 2023 to 2030, to $347.2 Mn by 2030. Germany Pharmacy Automation Device Market is growing due to Increasing Healthcare Expenditure, Rising Medication Errors, Technological Advancements. The market is primarily dominated by players such as Swisslog Healthcare, Becton, Dickinson and Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation.
The France Pharmacy Automation Device Market was valued at $151.2 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $274.7 Mn by 2030. France Pharmacy Automation Device Market is growing due to Growing Healthcare Expenses, Increased Medication Errors, Technological Advancements. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC.
The Mexico Pharmacy Automation Device Market was valued at $82.5 Mn in 2023 and is predicted to grow at a CAGR of 10.15% from 2023 to 2030, to $162.3 Mn by 2030. Mexico Pharmacy Automation Device Market is growing due to Increasing Demand for Efficiency, Rising Demand for Pharmaceuticals, Increasing adoption among end-users. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter.
The Brazil Pharmacy Automation Device Market was valued at $137.5 Mn in 2023 and is predicted to grow at a CAGR of 10.9% from 2023 to 2030, to $283.7 Mn by 2030. Brazil Pharmacy Automation Device Market is growing due to Increasing Healthcare Expenditure, Adoption of Electronic Health Records, Technological Advancements. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter.
The Saudi Arabia Pharmacy Automation Device Market was valued at $93.5 Mn in 2023 and is predicted to grow at a CAGR of 11.4% from 2023 to 2030, to $199.1 Mn by 2030. Saudi Arabia Pharmacy Automation Device Market is growing due to Increasing Demand for Efficiency, Adoption of Electronic Health Records, Increasing adoption among end-users. The market is primarily dominated by players such as Becton Dickinson and Co, Capsa Solutions LLC, Omnicell Inc, Oracle Corp, Veradigm LLC, Swisslog Healthcare AG, McKesson Corporation.
The US Pharmacy Automation Device Market was valued at $2310 Mn in 2023 and is predicted to grow at a CAGR of 7.9% from 2023 to 2030, to $3933.3 Mn by 2030. US Pharmacy Automation Device Market is growing due to Growing need to minimize medication errors, Rising Demand for Pharmaceuticals, and Increasing adoption among end-users. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC, Becton Dickinson and Company, Fulcrum Pharmacy Management, Inc.
The Canada Pharmacy Automation Device Market was valued at $440 Mn in 2023 and is predicted to grow at a CAGR of 9.9% from 2023 to 2030, to $852 Mn by 2030. Canada Pharmacy Automation Device Market is growing due to Adoption of Electronic Health Records, Reducing Human Errors, and Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC.